Discovery of the First-in-Class G9a/GLP Covalent Inhibitors

Park, Kwang-Su; Xiong, Yan; Yim, Hyerin; Velez, Julia; Babault, Nicolas; Kumar, Prashasti; Liu, Jing; Jin, Jian

doi:10.1021/acs.jmedchem.2c00652

Discovery of the First-in-Class G9a/GLP Covalent Inhibitors

Journal Article · 01 June 2022 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.2c00652· OSTI ID:1900776

Park, Kwang-Su; Xiong, Yan; Yim, Hyerin; Velez, Julia; Babault, Nicolas; Kumar, Prashasti; Liu, Jing; Jin, Jian

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; NIH

OSTI ID:: 1900776

Journal Information:: J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (15) Vol. 65

Country of Publication:: United States

Language:: ENGLISH

References (68)

Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor Shen, Yudao; Li, Fengling; Szewczyk, Magdalena M. Journal of Medicinal Chemistry, Vol. 63, Issue 10 https://doi.org/10.1021/acs.jmedchem.0c00406	journal	May 2020
Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease Majumder, Syamantak; Thieme, Karina; Batchu, Sri N. Journal of Clinical Investigation, Vol. 128, Issue 1 https://doi.org/10.1172/JCI95946	journal	December 2017
G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway Sun, Ting; Zhang, Keqiang; Pangeni, Rajendra P. Molecular Cancer Research, Vol. 19, Issue 3 https://doi.org/10.1158/1541-7786.MCR-20-0557	journal	March 2021
Tri-methylation of ATF7IP by G9a/GLP recruits the chromodomain protein MPP8 Tsusaka, Takeshi; Kikuchi, Masaki; Shimazu, Tadahiro Epigenetics & Chromatin, Vol. 11, Issue 1 https://doi.org/10.1186/s13072-018-0231-z	journal	October 2018
Chemical and Biochemical Perspectives of Protein Lysine Methylation Luo, Minkui Chemical Reviews, Vol. 118, Issue 14 https://doi.org/10.1021/acs.chemrev.8b00008	journal	June 2018
Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping Krivega, Ivan; Byrnes, Colleen; de Vasconcellos, Jaira F. Blood, Vol. 126, Issue 5 https://doi.org/10.1182/blood-2015-02-629972	journal	July 2015
Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader–Willi syndrome Kim, Yuna; Lee, Hyeong-Min; Xiong, Yan Nature Medicine, Vol. 23, Issue 2 https://doi.org/10.1038/nm.4257	journal	December 2016
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a Sweis, Ramzi F.; Pliushchev, Marina; Brown, Peter J. ACS Medicinal Chemistry Letters, Vol. 5, Issue 2 https://doi.org/10.1021/ml400496h	journal	January 2014
The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis Hua, Kuo-Tai; Wang, Ming-Yang; Chen, Min-Wei Molecular Cancer, Vol. 13, Issue 1 https://doi.org/10.1186/1476-4598-13-189	journal	August 2014
Selective Inhibitors of Protein Methyltransferases Kaniskan, H. Ümit; Konze, Kyle D.; Jin, Jian Journal of Medicinal Chemistry, Vol. 58, Issue 4 https://doi.org/10.1021/jm501234a	journal	December 2014
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation Antignano, Frann; Burrows, Kyle; Hughes, Michael R. Journal of Clinical Investigation, Vol. 124, Issue 5 https://doi.org/10.1172/JCI69592	journal	March 2014
Setd5is essential for mammalian development and co-transcriptional regulation of histone acetylation Osipovich, Anna B.; Gangula, Rama; Vianna, Pedro G. Development https://doi.org/10.1242/dev.141465	journal	January 2016
Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a Liu, Feng; Chen, Xin; Allali-Hassani, Abdellah Journal of Medicinal Chemistry, Vol. 52, Issue 24 https://doi.org/10.1021/jm901543m	journal	December 2009
The role of histone methylation in the development of digestive cancers: a potential direction for cancer management Chen, Yuan; Ren, Bo; Yang, Jinshou Signal Transduction and Targeted Therapy, Vol. 5, Issue 1 https://doi.org/10.1038/s41392-020-00252-1	journal	August 2020
Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase Butler, Kyle V.; Ma, Anqi; Yu, Wenyu Journal of Medicinal Chemistry, Vol. 59, Issue 21 https://doi.org/10.1021/acs.jmedchem.6b01244	journal	October 2016
MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis Tu, William B.; Shiah, Yu-Jia; Lourenco, Corey Cancer Cell, Vol. 34, Issue 4 https://doi.org/10.1016/j.ccell.2018.09.001	journal	October 2018
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia Zhu, Li; Li, Qin; Wong, Stephen H. K. Cancer Discovery, Vol. 6, Issue 7 https://doi.org/10.1158/2159-8290.CD-16-0058	journal	May 2016
ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression Wen, Hong; Li, Yuanyuan; Xi, Yuanxin Nature, Vol. 508, Issue 7495 https://doi.org/10.1038/nature13045	journal	March 2014
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure Milite, Ciro; Feoli, Alessandra; Horton, John R. Journal of Medicinal Chemistry, Vol. 62, Issue 5 https://doi.org/10.1021/acs.jmedchem.8b02008	journal	February 2019
Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B Cho, Hyun-Soo; Shimazu, Tadahiro; Toyokawa, Gouji Nature Communications, Vol. 3, Issue 1 https://doi.org/10.1038/ncomms2074	journal	January 2012
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors Zhang, Yi; Rong, Deqin; Li, Bingbing Journal of Medicinal Chemistry, Vol. 64, Issue 12 https://doi.org/10.1021/acs.jmedchem.0c02055	journal	February 2021
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP Liu, Feng; Barsyte-Lovejoy, Dalia; Li, Fengling Journal of Medicinal Chemistry, Vol. 56, Issue 21 https://doi.org/10.1021/jm401480r	journal	October 2013
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease Bhat, Kamakoti P.; Ümit Kaniskan, H.; Jin, Jian Nature Reviews Drug Discovery, Vol. 20, Issue 4 https://doi.org/10.1038/s41573-020-00108-x	journal	January 2021
Structure-activity relationship studies of G9a-like protein (GLP) inhibitors Xiong, Yan; Li, Fengling; Babault, Nicolas Bioorganic & Medicinal Chemistry, Vol. 25, Issue 16 https://doi.org/10.1016/j.bmc.2017.06.021	journal	August 2017
Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors Srimongkolpithak, Nitipol; Sundriyal, Sandeep; Li, Fengling MedChemComm, Vol. 5, Issue 12 https://doi.org/10.1039/C4MD00274A	journal	January 2014
Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease Zheng, Yan; Liu, Aiyi; Wang, Zi-Jun Brain, Vol. 142, Issue 3 https://doi.org/10.1093/brain/awy354	journal	January 2019
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact Black, Joshua C.; Van Rechem, Capucine; Whetstine, Johnathan R. Molecular Cell, Vol. 48, Issue 4 https://doi.org/10.1016/j.molcel.2012.11.006	journal	November 2012
SETD2 mutations in primary central nervous system tumors Viaene, Angela N.; Santi, Mariarita; Rosenbaum, Jason Acta Neuropathologica Communications, Vol. 6, Issue 1 https://doi.org/10.1186/s40478-018-0623-0	journal	November 2018
Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase Zhang, Yaling; Gao, Hongliang; Liu, Renjie Bioorganic & Medicinal Chemistry Letters, Vol. 27, Issue 18 https://doi.org/10.1016/j.bmcl.2017.08.035	journal	September 2017
The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer Bennett, Richard L.; Swaroop, Alok; Troche, Catalina Cold Spring Harbor Perspectives in Medicine, Vol. 7, Issue 6 https://doi.org/10.1101/cshperspect.a026708	journal	February 2017
Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model Griñán-Ferré, Christian; Marsal-García, Laura; Bellver-Sanchis, Aina Aging, Vol. 11, Issue 23 https://doi.org/10.18632/aging.102558	journal	December 2019
Regulation of p53 activity through lysine methylation Chuikov, Sergei; Kurash, Julia K.; Wilson, Jonathan R. Nature, Vol. 432, Issue 7015 https://doi.org/10.1038/nature03117	journal	November 2004
Lysine methylation signaling of non-histone proteins in the nucleus Levy, Dan Cellular and Molecular Life Sciences, Vol. 76, Issue 15 https://doi.org/10.1007/s00018-019-03142-0	journal	May 2019
Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase Subramanian, Krithika; Jia, Da; Kapoor-Vazirani, Priya Molecular Cell, Vol. 30, Issue 3 https://doi.org/10.1016/j.molcel.2008.03.022	journal	May 2008
Histone lysine methyltransferases in biology and disease Husmann, Dylan; Gozani, Or Nature Structural & Molecular Biology, Vol. 26, Issue 10 https://doi.org/10.1038/s41594-019-0298-7	journal	October 2019
Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines. Liu, Feng; Chen, Xin; Allali-Hassani, Abdellah Journal of Medicinal Chemistry, Vol. 53, Issue 15 https://doi.org/10.1021/jm100478y	journal	August 2010
A coupled fluorescent assay for histone methyltransferases Collazo, Evys; Couture, Jean-François; Bulfer, Stacie Analytical Biochemistry, Vol. 342, Issue 1 https://doi.org/10.1016/j.ab.2005.04.007	journal	July 2005
Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase Xiong, Yan; Li, Fengling; Babault, Nicolas Journal of Medicinal Chemistry, Vol. 60, Issue 5 https://doi.org/10.1021/acs.jmedchem.6b01645	journal	February 2017
Inhibitors of Protein Methyltransferases and Demethylases Kaniskan, H. Ümit; Martini, Michael L.; Jin, Jian Chemical Reviews, Vol. 118, Issue 3 https://doi.org/10.1021/acs.chemrev.6b00801	journal	March 2017
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression Segovia, Cristina; San José-Enériz, Edurne; Munera-Maravilla, Ester Nature Medicine, Vol. 25, Issue 7 https://doi.org/10.1038/s41591-019-0499-y	journal	July 2019
Emerging roles of lysine methylation on non-histone proteins Zhang, Xi; Huang, Yaling; Shi, Xiaobing Cellular and Molecular Life Sciences, Vol. 72, Issue 22 https://doi.org/10.1007/s00018-015-2001-4	journal	July 2015
CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions Butcher, Darci T.; Cytrynbaum, Cheryl; Turinsky, Andrei L. The American Journal of Human Genetics, Vol. 100, Issue 5 https://doi.org/10.1016/j.ajhg.2017.04.004	journal	May 2017
Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells Cao, Yue-peng; Sun, Jing-ya; Li, Mei-qian Acta Pharmacologica Sinica, Vol. 40, Issue 8 https://doi.org/10.1038/s41401-018-0205-5	journal	February 2019
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase Kubicek, Stefan; O'Sullivan, Roderick J.; August, E. Michael Molecular Cell, Vol. 25, Issue 3 https://doi.org/10.1016/j.molcel.2007.01.017	journal	February 2007
Structure of the UHRF1 Tandem Tudor Domain Bound to a Methylated Non-histone Protein, LIG1, Reveals Rules for Binding and Regulation Kori, Satomi; Ferry, Laure; Matano, Shohei Structure, Vol. 27, Issue 3 https://doi.org/10.1016/j.str.2018.11.012	journal	March 2019
Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation Liu, Xingui; Wang, Yingying; Zhang, Xuan Bioorganic & Medicinal Chemistry, Vol. 26, Issue 14 https://doi.org/10.1016/j.bmc.2018.06.013	journal	August 2018
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells Metzger, Eric; Wang, Sheng; Urban, Sylvia Nature Structural & Molecular Biology, Vol. 26, Issue 5 https://doi.org/10.1038/s41594-019-0219-9	journal	May 2019
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis Fang, Lan; Teng, Hongqi; Wang, Yilin Cancer Cell, Vol. 34, Issue 1 https://doi.org/10.1016/j.ccell.2018.06.002	journal	July 2018
Mechanism of G9a inhibitor BIX-01294 acting on U251 glioma cells Guo, Ai-Shun; Huang, Yi-Qun; Ma, Xu-Dong Molecular Medicine Reports, Vol. 14, Issue 5 https://doi.org/10.3892/mmr.2016.5815	journal	October 2016
Rapid Synthesis of Aryl Azides from Aryl Halides under Mild Conditions Liang, Xifu; Andersen, Jacob; Madsen, Ulf Synlett, Issue 14 https://doi.org/10.1055/s-2005-872248	journal	January 2005
Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2 Leenders, Ruben; Zijlmans, Remco; van Bree, Bart Bioorganic & Medicinal Chemistry Letters, Vol. 29, Issue 17 https://doi.org/10.1016/j.bmcl.2019.06.012	journal	September 2019
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Liu, Feng Nature Chemical Biology, Vol. 7, Issue 8 https://doi.org/10.1038/nchembio.599	journal	July 2011
Synthesis of enantiopure β2-homoalanine derivatives via rhodium catalyzed asymmetric hydrogenation Lühr, Susan; Holz, Jens; Zayas, Odalys Tetrahedron: Asymmetry, Vol. 24, Issue 7 https://doi.org/10.1016/j.tetasy.2013.02.011	journal	April 2013
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy Rabal, Obdulia; San José-Enériz, Edurne; Agirre, Xabier Journal of Medicinal Chemistry, Vol. 61, Issue 15 https://doi.org/10.1021/acs.jmedchem.7b01926	journal	June 2018
Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders Faundes, Víctor; Newman, William G.; Bernardini, Laura The American Journal of Human Genetics, Vol. 102, Issue 1 https://doi.org/10.1016/j.ajhg.2017.11.013	journal	January 2018
G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis Tachibana, M. Genes & Development, Vol. 16, Issue 14 https://doi.org/10.1101/gad.989402	journal	July 2002
Lysine Methylation Regulators Moonlighting outside the Epigenome Cornett, Evan M.; Ferry, Laure; Defossez, Pierre-Antoine Molecular Cell, Vol. 75, Issue 6 https://doi.org/10.1016/j.molcel.2019.08.026	journal	September 2019
Distinct Roles for Histone Methyltransferases G9a and GLP in Cancer Germ-Line Antigen Gene Regulation in Human Cancer Cells and Murine Embryonic Stem Cells Link, Petra A.; Gangisetty, Omkaram; James, Smitha R. Molecular Cancer Research, Vol. 7, Issue 6 https://doi.org/10.1158/1541-7786.MCR-08-0497	journal	June 2009
Critical roles of non-histone protein lysine methylation in human tumorigenesis Hamamoto, Ryuji; Saloura, Vassiliki; Nakamura, Yusuke Nature Reviews Cancer, Vol. 15, Issue 2 https://doi.org/10.1038/nrc3884	journal	January 2015
Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease Katayama, Katsushi; Ishii, Ken; Terashima, Hideki ACS Medicinal Chemistry Letters, Vol. 12, Issue 1 https://doi.org/10.1021/acsmedchemlett.0c00572	journal	December 2020
Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines Katayama, Katsushi; Ishii, Ken; Tsuda, Eisuke Bioorganic & Medicinal Chemistry Letters, Vol. 30, Issue 20 https://doi.org/10.1016/j.bmcl.2020.127475	journal	October 2020
Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling Deng, Xiaolan; Hamamoto, Ryuji; Vougiouklakis, Theodore Oncotarget, Vol. 8, Issue 34 https://doi.org/10.18632/oncotarget.19646	journal	July 2017
Nonhistone Lysine Methylation in the Regulation of Cancer Pathways Carlson, Scott M.; Gozani, Or Cold Spring Harbor Perspectives in Medicine, Vol. 6, Issue 11 https://doi.org/10.1101/cshperspect.a026435	journal	August 2016
Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines Liu, Feng; Barsyte-Lovejoy, Dalia; Allali-Hassani, Abdellah Journal of Medicinal Chemistry, Vol. 54, Issue 17 https://doi.org/10.1021/jm200903z	journal	September 2011
G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer Bergin, Christopher J.; Zouggar, Aïcha; Haebe, Joshua R. Oncogene, Vol. 40, Issue 6 https://doi.org/10.1038/s41388-020-01591-7	journal	December 2020
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies San José-Enériz, Edurne; Agirre, Xabier; Rabal, Obdulia Nature Communications, Vol. 8, Issue 1 https://doi.org/10.1038/ncomms15424	journal	May 2017
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases Chang, Yanqi; Ganesh, Thota; Horton, John R. Journal of Molecular Biology, Vol. 400, Issue 1 https://doi.org/10.1016/j.jmb.2010.04.048	journal	July 2010
Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis Kato, Shinichiro; Weng, Qing Yu; Insco, Megan L. Cancer Discovery, Vol. 10, Issue 7 https://doi.org/10.1158/2159-8290.CD-19-0532	journal	July 2020

Similar Records

Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase

Journal Article · 2017 · Journal of Medicinal Chemistry · OSTI ID:1373766

Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases

Journal Article · 2012 · J. Biol. Chem. · OSTI ID:1049551

Structure-activity relationship studies of G9a-like protein (GLP) inhibitors

Journal Article · 2017 · Bioorganic and Medicinal Chemistry · OSTI ID:1390876

Discovery of the First-in-Class G9a/GLP Covalent Inhibitors

Citation Formats

References (68)

Similar Records

Related Subjects